Domov › Rabdomysarkóm › Texas
Klinické štúdie Rabdomysarkóm v štáte Texas
9 štúdií pre Rabdomysarkóm hľadá účastníkov v zariadeniach v štáte Texas.
Mestá v štáte Texas
Oficiálny text štúdie (anglicky)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- University of Texas - MD Anderson Cancer Center, Houston
Prebieha náborFáza 1
24 Months – 18 Years · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Medical Center, Dallas
Prebieha náborFáza 1/2
Do veku 30 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- a 2 ďalších
Prebieha náborFáza 3
Do veku 50 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07466316Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
Prebieha náborFáza 1
Vek 1 až 21 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT04715191PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Texas Children's Hospital, Houston
Prebieha náborFáza 1/2
Vek 1 až 30 · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT06721689Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Cook Children's Medical Center, Fort Worth
Prebieha náborFáza 2
Do veku 22 · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT06023641VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- The University of Texas Southwestern Medical Center, Dallas
- Texas Children's Hospital, Houston
Prebieha náborFáza 1/2
6 Months – 30 Years · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT04796012HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
Prebieha náborFáza 1
Vek 1 až 25 · Všetky pohlavia · Aktualizované 22. 1. 2026 · NCT04995003Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Houston Methodist Hospital, Houston
Prebieha náborFáza 1
Do veku 21 · Všetky pohlavia · Aktualizované 3. 11. 2025 · NCT06198296Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.